Medicare fee cut, ICD-10 delayed for 1 year

Article

Congress has approved legislation delaying for 1 year a massive 24% Medicare fee cut, which had been scheduled to take effect April 1, as well as implementation of the ICD-10-CM coding system.

 

Washington, DC-Congress has approved legislation delaying for 1 year a massive 24% Medicare fee cut, which had been scheduled to take effect April 1, as well as implementation of the ICD-10-CM coding system.

The Senate approved the Protecting Access to Medicare Act (H.R. 4302) on a 64-35 vote Monday night (March 31), following approval on a voice vote in the House of Representatives last Thursday (March 27).

Instead of a pay cut, as required under Medicare's Sustainable Growth Rate (SGR) fee-setting formula, the legislation grants Medicare physicians a 0.5% pay increase through March 31, 2015. Medicare carriers will hold off on processing claims filed during the first 10 days of April to allow time for enactment of the legislation and necessary system changes.

ICD-10-CM coding will now be required for diagnoses on all public- and private-sector insurance plan claims beginning October 1, 2015, instead of the same date this year. 

The legislation is the latest in a series of 17 temporary “doc fix” bills enacted since 2002 to spare physicians Medicare pay cuts required under the SGR fee-setting formula. It comes as a disappointment  to healthcare provider organizations, including the American Optometric Association (AOA), which hoped Congress would permanently remove the SGR from the Medicare fee formula this year.

Says AOA President Mitchell T. Munson: “Whether Congress continues to go with temporary Medicare payment ‘patches’ or moves ahead with a much-needed long-term solution, the AOA has made it clear to both House and Senate leaders that our full physician status in Medicare is non-negotiable. Over the last year, thanks to the hard work done by the AOA and optometry’s army of grassroots advocates, we were successful in securing optometry-specific changes to all of the advancing Medicare payment bills. Now, with a new year-long patch in place and more uncertainty ahead, we must continue to do what it takes to be heard loud and clear on Capitol Hill.”

As late as Monday afternoon, Senate Finance Committee Chairman Ron Wyden (D-Ore.) was hoping to win approval of a comprehensive Medicare payment reform bill, The SGR Repeal and Medicare Payment Modernization Act (S. 2000, HR 4015), which would have guaranteed a 0.5 percent increase in physician reimbursements through 2018.   

That comprehensive Medicare reform package was praised as a rare example of bipartisan cooperation, when it was jointly released by the House Ways and Means, House Energy and Commerce, and Senate Finance committees on Feb. 6.

However, House Republicans added a provision delaying the Affordable

Care Act's (ACA) individual insurance mandate before passing the bill earlier this month. Democratic leaders in the Senate promptly announced they would not consider the amended legislation and the White House announced President Obama would not sign it. (See Optometry Times Special Report, March 21, 2014.)

House members then quickly formulated and passed the temporary doc fix bill, including, to the surprise of some observers, a delay in the ICD-10-CM deadline.

ICD-9-CM codes are designed to provide much more specific reporting of diagnoses than the now-used ICD-9-CM code set. There are approximately 70,000 ICD-10-CM codes, compared with approximately 14,000 ICD-9-CM codes. Implementation is considered a challenge by some practitioners. The U.S. Centers for Medicare & Medicaid Services (CMS) recommends health care practice phase-in use of the ICD-10 codes over at least a nine-month period. 

Under the SGR fee-setting formula, Medicare physicians were to see reimbursements cut 24 percent on January 1, 2014. However, Congress late last year passed a temporary “pay patch” bill, providing a 0.5% increase through March 31.

The SGR was added to the Medicare fee-setting formula under the federal Balanced Budget Act of 1997 in an effort to curb growing Medicare costs. The statistic is used to tie Medicare cost increases to the Gross Domestic Product. However, instead of limiting annual Medicare Part B reimbursements, the revised formula has prompted the U. S. Centers for Medicare and Medicaid Services (CMS) to annually propose increasingly steep reimbursements cuts. During all but 1 year, Congress has intervened at the last minute to either freeze or nominally increase Medicare pay rates.

The SGR repeal would cost $138 billion over the next 10 years, according to the Congressional Budget Office (CBO). House Republicans had hoped to partially offset that cost by delaying the ACA individual mandate, a step that would save about $9 billion over the same period, according to the CBO. Sen Wyden   proposed covering the cost with savings in military spending as the U.S. draws down forces in Afghanistan.

The new doc fix bill now give lawmakers another year to find funding to cover permanent repeal of the SGR. 

 

Bob Pieper, a former senior editor at the American Optometric Association, is a longtime writer in optometry. Reach him at rfpieper@outlook.com.  

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.